Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Patented Medicines (Notice of Compliance) Regulations (SOR/93-133)

Regulations are current to 2024-11-26 and last amended on 2017-09-21. Previous Versions

RELATED PROVISIONS

  • — SOR/2006-242, s. 6

  • — SOR/2006-242, s. 7

      • 7 (1) Subsection 5(1) of the Patented Medicines (Notice of Compliance) Regulations, as enacted by section 2 of these Regulations, applies to a second person who has filed a submission referred to in subsection 5(1) prior to the coming into force of these Regulations and the date of filing of the submission is deemed to be the date of the coming into force of these Regulations.

      • (2) Subsection 5(2) of the Patented Medicines (Notice of Compliance) Regulations, as enacted by section 2 of these Regulations, applies to a second person who has filed a supplement to a submission referred to in subsection 5(2) prior to the coming into force of these Regulations and the date of filing of the supplement is deemed to be the date of the coming into force of these Regulations.

  • — SOR/2006-242, s. 8

  • — SOR/2017-166, s. 9

      • 9 (1) The Patented Medicines (Notice of Compliance) Regulations, as they read immediately before the day on which these Regulations come into force, continue to apply in respect of any matter that relates to a notice of allegation served on a first person before that day.

      • (2) For greater certainty, sections 6 to 8 of the Regulations Amending the Patented Medicines (Notice of Compliance) Regulations, SOR/2006-242, continue to apply in respect of the provisions set out in those sections.


Date modified: